The U.S. FDA has approved the broader use of GSK’s RSV vaccine for adults aged 50 to 59. Additionally, a Texas bird flu strain has been found lethal to ferrets, drawing concern from the CDC. U.S. agencies plan to research bird flu’s respiratory spread in dairy cattle to manage and reduce human exposure.
US FDA expands GSK’s RSV vaccine approval to adults aged 50 to 59.
The U.S. Food and Drug Administration approved the expanded use of GSK’s respiratory syncytial virus (RSV) vaccine on Friday in adults aged between 50 and 59, making it the first shot endorsed for that age group. The shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for people aged 60 and older for the virus.
Texas bird flu strain kills ferrets used to mimic disease in humans, US CDC says
US to research possible respiratory spread of bird flu in cows
U.S. federal and state agencies are planning research into potential respiratory spread of bird flu among dairy cattle, according to a Reuters interview with Michigan state agriculture and public health officials. Scientists and government officials hope the research will guide efforts to contain the virus and reduce exposure to humans. Respiratory spread could give the virus more opportunity to evolve, they said.
You can now read the most important #news on #eDairyNews #Whatsapp channels!!!
🇮🇳 eDairy News ÍNDIA: https://whatsapp.com/channel/0029VaPidCcGpLHImBQk6x1F
